Gene therapy in peripheral artery disease (Q58362653)

peripheral artery disease

Europe PubMed Central

title

Gene therapy in peripheral artery disease (English)

0 references

main subject

1 reference

7

Hiromi Rakugi

0 references

author name string

Fumihiro Sanada

1

0 references

Yoshiaki Taniyama

2

0 references

Yasuhiro Kanbara

3

0 references

Rei Otsu

4

0 references

Yuka Ikeda-Iwabu

5

0 references

Miguel Carracedo

6

0 references

Ryuichi Morishita

Expert Opinion on Biological Therapy

8

0 references

language of work or name

English

0 references

publication date

29 January 2015

0 references

published in

0 references

volume

15

0 references

page(s)

381-390

0 references

issue

3

0 references

cites work

Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS).

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Executive Summary: Heart Disease and Stroke Statistics—2014 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Peripheral arterial disease detection, awareness, and treatment in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Critical issues in peripheral arterial disease detection and management: a call to action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Therapeutic angiogenesis for critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Advances in cell-based therapy for peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

The myopathy of peripheral arterial occlusive disease: Part 2. Oxidative stress, neuropathy, and shift in muscle fiber type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Vascular cell senescence: contribution to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Therapeutic angiogenesis: a new frontier for vascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Human studies of angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inflammation in peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Oncogene-induced cellular senescence: causal factor in the growth arrest of pituitary microadenomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Endothelial progenitor cell senescence--is there a role for estrogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor inhibits lipopolysaccharide-induced oxidative stress via epithelial growth factor receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Cardiac Stem Cells Possess Growth Factor-Receptor Systems That After Activation Regenerate the Infarcted Myocardium, Improving Ventricular Function and Long-Term Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Peripheral arterial disease: morbidity and mortality implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Local delivery of plasmid DNA into rat carotid artery using ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039

Gene therapy for gastric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2015.1007039